Top Premarket Decliners
CCH (CCHH) shares were down 28% in Thursday premarket activity after the company announced a 1-for-10 share consolidation of its issued and outstanding Class A and Class B shares. Aimei Health Technology (AFJK) stock was down 30% after the company terminated its merger agreement with United Hydrogen Group. Investcorp Credit Management (ICMB) shares were down 21%, extending the previous session's 6% decline. Ionis Pharmaceuticals (IONS) stock was down 18% after a phase 3 trial of eplontersen failed to meet the primary efficacy endpoint in patients with transthyretin-mediated amyloid cardiomyopathy. Catheter Precision (VTAK) stock was down 14%, following the previous session's 92% gain.
CCH (CCHH) shares were down 28% in Thursday premarket activity after the company announced a 1-for-10 share consolidation of its issued and outstanding Class A and Class B shares.
Aimei Health Technology (AFJK) stock was down 30% after the company terminated its merger agreement with United Hydrogen Group.
Investcorp Credit Management (ICMB) shares were down 21%, extending the previous session's 6% decline.
Ionis Pharmaceuticals (IONS) stock was down 18% after a phase 3 trial of eplontersen failed to meet the primary efficacy endpoint in patients with transthyretin-mediated amyloid cardiomyopathy.
Catheter Precision (VTAK) stock was down 14%, following the previous session's 92% gain.